Core Insights - McKesson reported quarterly earnings of $9.86 per share, exceeding the Zacks Consensus Estimate of $8.92 per share, and up from $7.07 per share a year ago, representing an earnings surprise of +10.54% [1][2] - The company posted revenues of $103.15 billion for the quarter ended September 2025, which missed the Zacks Consensus Estimate by 1.45%, compared to $93.65 billion in the same quarter last year [2] - McKesson's stock has increased approximately 47.7% year-to-date, significantly outperforming the S&P 500's gain of 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $9.99, with expected revenues of $105.75 billion, and for the current fiscal year, the EPS estimate is $38.05 on revenues of $409.17 billion [7] - The estimate revisions trend for McKesson was favorable prior to the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical - Dental Supplies industry, to which McKesson belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - The performance of McKesson's stock may also be influenced by the overall industry outlook, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]
McKesson (MCK) Surpasses Q2 Earnings Estimates